Valuation: DexCom, Inc.

Market Cap 27.56B 140B 24.15B 22.42B 20.6B 38.82B 2,660B 39.39B 267B 105B 1,301B 103B 101B 4,496B P/E 2026 *
29.2x
P/E 2027 * 24.5x
Enterprise Value 27.13B 137B 23.77B 22.07B 20.28B 38.22B 2,618B 38.78B 263B 103B 1,281B 102B 99.66B 4,426B EV / Sales 2026 *
5.19x
EV / Sales 2027 * 4.51x
Free-Float
93.34%
Yield 2026 *
-
Yield 2027 * -
1 day+2.71%
1 week-9.19%
Current month+2.71%
1 month+1.41%
3 months+15.18%
6 months-7.09%
Current year-3.74%
1 week 7.21
Extreme 7.21
7.78
1 month 7.02
Extreme 7.02
7.98
Current year 5.75
Extreme 5.75
8.14
1 year 5.75
Extreme 5.75
10.06
3 years 5.75
Extreme 5.75
14.45
5 years 5.75
Extreme 5.75
18.3
10 years 5.75
Extreme 5.75
18.3
Manager TitleAgeSince
Chief Executive Officer 47 2025-12-31
Director of Finance/CFO 46 2021-03-18
Chief Tech/Sci/R&D Officer - 2024-04-30
Director TitleAgeSince
Chairman 68 2018-07-29
Director/Board Member 67 2009-11-19
Director/Board Member 47 2025-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+2.71%-9.19% - - 28.84B
+0.90%+12.66%-20.01%-12.00% 174B
-0.56%+1.76%-10.65%-7.95% 105B
-0.82%+1.35%+2.60%+56.07% 58.97B
-1.38%-1.40%+32.87%+55.64% 52.24B
-0.44%-1.11%-15.51%-42.17% 42.39B
-4.89%-5.73% - - 33.05B
-0.23%-0.16%+63.73%-5.01% 25.38B
-0.56%-0.42%-5.87%-9.27% 20.64B
-2.89%-3.10%-13.61%-3.97% 20.28B
Average -0.60%+0.86%+4.19%+3.92% 59.11B
Weighted average by Cap. +0.03%+4.04%-4.34%+2.21%

Financials

2026 *2027 *
Net sales 5.22B 26.46B 4.58B 4.25B 3.9B 7.36B 504B 7.47B 50.62B 19.81B 247B 19.61B 19.19B 852B 5.83B 29.51B 5.11B 4.74B 4.36B 8.21B 562B 8.33B 56.46B 22.1B 275B 21.87B 21.4B 950B
Net income 959M 4.86B 841M 780M 717M 1.35B 92.58B 1.37B 9.3B 3.64B 45.3B 3.6B 3.52B 156B 1.16B 5.86B 1.01B 941M 865M 1.63B 112B 1.65B 11.21B 4.39B 54.65B 4.34B 4.25B 189B
Net Debt -429M -2.17B -376M -349M -320M -604M -41.37B -613M -4.15B -1.63B -20.24B -1.61B -1.57B -69.93B -1.28B -6.49B -1.12B -1.04B -957M -1.8B -124B -1.83B -12.41B -4.86B -60.47B -4.81B -4.7B -209B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
26-07-22 R$7.210 -0.83% 25
26-07-20 R$7.270 -6.56% 5
26-07-17 R$7.780 -1.52% 1
26-07-16 R$7.900 -0.50% 241
26-07-14 R$7.940 +2.06% 25,959
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
71.43USD
Average target price
85.75USD
Spread / Average Target
+20.05%

Quarterly revenue - Rate of surprise